Several investigations have reported that mice administered paraquat dichloride (PQÁCl 2 ) by intraperitoneal injection exhibit a loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). In this study, male and female C57BL/6J mice were administered PQÁCl 2 in the diet at concentrations of 0 (control), 10, and 50 ppm for a duration of 13 weeks. A separate group of mice were administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) during week 12 as positive controls to produce a loss of dopaminergic neurons in the SNpc. The comparative effects of PQ and MPTP on the SNpc and/or striatum were assessed using neurochemical, neuropathological, and stereological endpoints. Morphological and stereological assessments were performed by investigators 'blinded' to the origin of the tissue. Neither dose of PQÁCl 2 (10 or 50 ppm in the diet) caused a loss of striatal dopamine or dopamine metabolite concentrations in the brains of mice. Pathological assessments of the SNpc and striatum showed no evidence of neuronal degeneration or astrocytic/microglial activation. Furthermore, the number of tyrosine hydroxylase-positive (TH + ) neurons in the SNpc was not reduced in PQ-treated mice. In contrast, MPTP caused a decrease in striatal dopamine concentration, a reduction in TH + neurons in the SNpc, and significant pathological changes including astrocytic and microglial activation in the striatum and SNpc. The MPTPinduced effects were greater in males than in females. It is concluded that 13 weeks of continuous dietary exposure of C57BL/6J mice to 50 ppm PQÁCl 2 (equivalent to 10.2 and 15.6 mg PQ ion/kg body weight/day for males and females, respectively) does not result in the loss of, or damage to, dopaminergic neurons in the SNpc.
Introduction
Parkinson's disease (PD) is a progressive neurodegenerative disorder that is typically characterized by motor symptoms (tremor, bradykinesia, rigidity, and postural instability) that are attributed to the degeneration and death of dopaminergic neurons in the substantia nigra pars compacta (SNpc). MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) has been used as an animal model of PD because it causes dopaminergic neuronal cell death and the loss of dopaminergic neurons in the SNpc (Jackson- Lewis et al., 1995 Lewis et al., , 2012 Jackson-Lewis and Smeyne, 2005) . The non-selective herbicide paraquat (1,1 0 -dimethyl-4,4 0 -bipyridinium; PQ) has also been considered by some (Nistico et al., 2011; Ossowska et al., 2005) , but not others (Miller, 2007; Richardson et al., 2005) , to be a suitable animal model of PD. PQ appears to be structurally similar to the MPTP metabolite and proximate toxicant MPP + , and by the use of stereological techniques, several investigators (Brooks et al., 1999; Gollamudi et al., 2012; Jiao et al., 2012; McCormack et al., 2002; Peng et al., 2004; Yin et al., 2011) typically in the C57BL/6J male mouse. We have recently reported an inability to replicate this finding (Breckenridge et al., 2013) . Furthermore, an intensive, ''blinded'' neuropathological evaluation did not find any evidence of PQ-induced cell death in multiple brain regions, including the SNpc and striatum, as indicated by an absence of silver staining of neurons, indicators of apoptosis, or evidence of glial or astrocytic activation (Breckenridge et al., 2013) .
In the majority of studies that evaluated the neurotoxicity of PQ, the chemical was administered by ip injection, typically once weekly for several weeks. The systemic exposure to PQ after ip administration does not reflect human exposure in normal agricultural use of PQ (Lock and Wilks, 2001) . It is generally accepted that spray operators using PQ are likely to experience the greatest exposure to PQ in an agricultural setting. Worker exposure studies have shown that the dermal route dominates human exposure in PQ user scenarios, whether these exposures involve applications by knapsack (Chester and Woollen, 1982; Staiff et al., 1975; Van Wendel de Joode et al., 1996) , applications by tractor (Forbess et al., 1982; Staiff et al., 1975; Wojeck et al., 1983) , or by aircraft (Chester and Ward, 1984) . However, mouse skin poorly replicates the absorption characteristics of human skin, being at least two orders of magnitude more permeable to PQ (Scott et al., 1986 ). Chui and associates (Chui et al., 1988) have shown that in the rodent an oral (gavage) dose and a dermal dose both result in a peak PQ concentration in blood 40-60 min after dosing, whereas an ip dose results in a peak PQ concentration in blood at 12-15 min post dose (Breckenridge et al., 2013) . Since it is difficult to mimic the dermal route of exposure over a prolonged period using mice, we have chosen the oral route of exposure as this provides a convenient measurable dose level and leads to prolonged systemic exposure analogous to that achieved by the slow absorption of PQ through the skin. The use of a 13 week dietary study to assess safety in pesticide application scenarios also follows conventional regulatory practice.
In the present study, mice were exposed to PQÁCl 2 at dietary concentrations of 10 or 50 ppm for 13 weeks. Achieved dose levels at 50 ppm were 10.2 mg and 15.6 mg PQ ion/kg body weight (bw)/ day, and the predicted maximum PQÁCl 2 concentrations in the brain were 416 and 655 ng/g tissue, for males and females, respectively. The mice exposed to PQÁCl 2 in their diets showed no loss of striatal dopamine or dopamine metabolite concentrations, no evidence of neuronal degeneration or astrocytic/microglial activation, and no reduction in the number of tyrosine hydroxylase-positive (TH + ) neurons in the SNpc. A group of mice treated with MPTP served as a positive control to validate the various assessments used in this study to detect neurotoxic insult.
Methods

Dietary kinetic study
Prior to the assessment of neurotoxicity, a preliminary study was conducted at Charles River Laboratories (UK) in compliance with Good Laboratory Practice Regulations to determine brain PQ concentrations in mice following dietary exposure. Groups of male and female C57BL/6J mice were provided PQÁCl 2 as a dietary admix for up to 13 weeks to investigate PQ brain and plasma kinetics. The PQÁCl 2 concentration in each diet was adjusted weekly (based on mean body weight and food consumption data) to achieve target dose levels of either 0.3 or 1.5 mg PQÁCl 2 /kg bw/day. A subgroup of high-dose mice were used to assess PQ brain and plasma kinetics during 8 weeks of recovery subsequent to 13 weeks of dietary PQ treatment. Dietary formulations were prepared using a certified rodent diet (Rat and Mouse [modified] Diet No. 1 SQC expanded [Ground] , Special Diets Services, Stepfield, Witham, UK). At each sample collection time point (7, 56, and 90 days at both dose levels; and 120 and 150 days at the high-dose level only) a potassium EDTA blood tube was used to collect a 300 lL blood sample from each mouse via the saphenous vein. Plasma was obtained from each sample following centrifugation. Following euthanasia by cervical dislocation, the brain was collected and weighed. Brain and plasma samples (n = 4 mice/sex/group at each time point) were stored at À20°C, and subsequently analyzed for PQ content by HPLC-MS/MS.
To compare the brain concentrations achieved in the dietary study to studies in which the ip route was used, a PBPK model based on earlier work (Breckenridge et al., 2013 ) was used to simulate a 13 week dietary exposure to PQ in male and female mice. Physiological parameters for the mouse were taken from Brown and associates (Brown et al., 1997) . Food intake was simulated using the hourly fraction of diet ingested (Yuan, 1993) . Body weight, reported on a weekly basis, was input as a linear interpolation between each week over the course of the study. The daily ingested dose was determined based on the weekly reported exposure (mg/kg bw/day), and was kept constant over the 7 day period. The simulation of dietary intake was used to produce time-course concentrations expressed as ng/g or ng/mL of PQÁCl 2 in brain and plasma, respectively. Both the dietary kinetic study and the neurotoxicology study were simulated in this way. Simulations of the dietary kinetic study were compared to simulations of ip dosing, as ip injection is the most commonly used route in studies of PQ neurotoxicity. The total systemic PQ dose resulting from the first 7 days of dietary dosing was estimated using the PBPK model, and was divided by seven to give the daily ip dose to be simulated.
Dietary neurotoxicity study
Study conduct
The 13 (Frederick, MD) ; both NSA and the pathologist were ''blinded'' to treatment group. Brain tissues for stereological investigations were prepared and evaluated by a stereologist at Experimental Pathology Laboratories (EPL, Sterling, VA), who was also ''blinded'' to treatment group.
Study design
The control and test diets were offered continuously for 13 weeks (91-95 consecutive days). Mice were assigned to four treatment groups (control, 10 ppm PQÁCl 2 , 50 ppm PQÁCl 2 , and MPTP). Control and MPTP groups were provided a basal diet for the duration of the study. PQÁCl 2 was administered in the diet as a constant concentration of either 10 or 50 ppm. These dietary concentrations of 10 and 50 ppm were selected to achieve dose levels of at least 1.2 and 6.0 mg (ion)/kg bw/day, respectively, over a 90 day period. These two doses were adequately spaced to allow the observation of any potential dose response, and the top dose level was expected not to exceed the maximum tolerated dose for mice of this strain.
MPTP was administered 7 days prior to scheduled euthanasia (at the beginning of week 12) as four successive ip injections; each at a dose of 10 mg (free base)/kg bw, spaced at approximately 2 h intervals. This dose route and dosing regimen have been shown to produce a reliable and reproducible lesion of the nigrostriatal dopaminergic pathway (Breckenridge et al., 2013; Jackson-Lewis and Przedborski, 2007) . The dose volume for the MPTP group was 2.5 mL/kg bw/dose; individual doses were based on the most recently-recorded body weights.
Preparation of paraquat diets
Diets were prepared with PQÁCl 2 having a 99.9% purity (Syngenta, Lot Number ASJ10083-03). Prior to use, the PQÁCl 2 was dried in an oven set at approximately 100°C for a minimum of 4 h. The 50 ppm dietary formulation was prepared by adding PQÁCl 2 to the powdered diet (PMI Nutrition International, LLC Certified Rodent LabDiet Ò 5002) and mixing with a blender. A portion of the 50 ppm test diet was then diluted with additional basal diet to obtain the 10 ppm dietary formulation. The test diets were prepared at approximately weekly intervals. Analysis of dietary samples collected at various intervals throughout the study indicated that dietary PQÁCl 2 concentrations ranged from 91.5% to 116% of the target concentrations.
Preparation of MPTP dosing solution
MPTPÁHCl was obtained from Sigma-Aldrich, Inc., St. Louis, MO (Batch Number 090M1522V) and stored at room temperature. MPTPÁHCl was formulated as a solution in physiological (0.9%) saline at 4.0 mg (free base)/mL. The concentration of MPTP was verified by HPLC to be 103% of the target concentration.
Test animal/animal husbandry
Male and female C57BL/6J mice, 7 weeks of age, were supplied by Jackson Laboratories, Bar Harbor, ME. Mice were housed in individual, stainless-steel, wire-mesh-floored cages. Individual body weight and food consumption data were recorded weekly for all animals. A 12-h light-dark photoperiod was maintained throughout the study; room temperature and relative humidity were maintained at 22 ± 3°C and 50% ± 20%, respectively. One week prior to initiation of PQ treatment, the mice were randomly assigned to control and treatment groups using a randomized block design, stratified by weight. Treatment with PQ (or basal diet) commenced at 10 weeks of age, and MPTP administration occurred when the mice were 22 weeks of age.
Striatal neurochemistry
During week 13, mice designated for striatal neurochemistry (n = 6 mice/sex/group) were euthanized by cervical dislocation, followed by decapitation and brain removal. The striatal tissue was isolated, weighed, and flash-frozen in liquid nitrogen. Striatal concentrations of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA) were determined by HPLC coupled with electrochemical detection, as described previously (Breckenridge et al., 2013) . Dopamine turnover was calculated
Striatal and SNpc neuropathology
Control, 10 ppm PQÁCl 2, and 50 ppm PQÁCl 2 mice designated for neuropathology assessment were euthanized after 31, 59, or 94 days of exposure (n = 5 mice/sex/group/interval). MPTP mice designated for neuropathology assessment (n = 5 mice/sex) were euthanized during study week 13 (7 days following MPTP treatment). Mice were anesthetized (sodium pentobarbital ip) and perfused in situ with 25 mL of sodium cacodylate buffer, followed by perfusion with 75 mL of sodium cacodylate-based 4% paraformaldehyde (methanol free). The heads were placed in cacodylatebased 4% paraformaldehyde for 24 h. The brains were then removed from the skulls, placed into the sodium cacodylate buffer solution, and maintained refrigerated. The brains were shipped to Neuroscience Associates, Inc., where they were trimmed, multi-embedded, and sectioned at 30 lm in the coronal plane. Serial sections were produced and stained using amino cupric silver (Am Cu Ag) stain for neuronal necrosis (de Olmos et al., 1994) (Breckenridge et al., 2013) . All slides were shipped to Tox Path Specialists, LLC for examination. Microscopic examination was performed in a ''blinded'' manner; the pathologist was not aware of the treatment group to which the individual mouse brain sections belonged. Neuropathology data were recorded according to a semi-quantitative scoring system, as previously described (Breckenridge et al., 2013) , including analysis for the presence of necrotic cells, the character of any glial reaction, an assessment of the degree of dopaminergic neuron loss (if any), and an assessment of the possible mechanism for the loss.
SNpc stereology
After 91-94 days of exposure, mice designated for stereological assessment of the number of TH + neurons in the SNpc (20 mice/ sex/group) were anesthetized (sodium pentobarbital ip) and perfused in situ with chilled 0.9% physiological saline, followed by 4% paraformaldehyde (pH approximately 9.5), using a flow rate of approximately 10 mL/min. The perfusion-fixed brains (including olfactory bulbs) were preserved in 4% paraformaldehyde, and then shipped to Experimental Pathology Laboratories, Inc. for further processing, sectioning, staining, and stereological assessment, as described by Breckenridge and associates (Breckenridge et al., 2013) . Immunostaining of dopaminergic neurons was performed according to the standard avidin-biotin complex (ABC) method [primary antibody: polyclonal anti-tyrosine antibody of rabbit origin (EMD Millipore, Billerica, MA) at a 1:1000 dilution; secondary antibody: biotinylated goat anti-rabbit IgG (Vector Laboratories, Inc.) at a 1:1000 dilution]. The stereological assessment was performed in a ''blinded'' manner (i.e., the investigator was not aware of the treatment group). The total number of TH + neurons in the SNpc was estimated using the optical fractionator approach (West et al., 1991) , which employed an unbiased systematic random sampling methodology. Accordingly, neuron cell bodies were counted in a subsample of sections, section thicknesses, and section areas, and then the results were extrapolated to provide estimates of total numbers of TH + neurons in the left and right SNpc. The following stereological parameters were used in this study: section sampling frequency = one of three SNpc containing sections; counting frame interval = 120 Â 120 mm; counting frame size = 60 Â 60 lm; dissector height = 4 lm; and upper guard zone = 2 lm.
Statistical analysis
The effects of treatment on the concentrations of dopamine, dopamine metabolites (DOPAC, HVA), and dopamine turnover were analyzed using ANOVA. When the ANOVA analysis revealed significant (p < 0.05) intergroup variance, Dunnett's test (Dunnett, 1964) was used to compare the values from PQ and MPTP groups to the negative control group values.
The effects of treatment (PQ or MPTP) on the mean number of dopaminergic neurons in the substantia nigra pars compacta (SNpc), as determined by stereological analysis, was assessed using a onesided t-test. Differences in means were considered statistically significant at p 6 0.05.
Group mean scores based on the categorical classification of microscopic findings were calculated by Tox Path Specialists, LLC, but statistical analyses were not conducted.
Results
Paraquat kinetic study
The average doses over 90 days in the kinetic study were within 2% of the target doses of 0.3 and 1.5 mg/kg bw/day. PQ brain kinetics in male and female mice were not significantly different, so the mean brain PQ concentrations of the two sexes were combined, as shown in Fig. 1 . Based on earlier work (Breckenridge et al., 2013 ), a PBPK model was used to simulate the kinetic study. Simulated PQ brain concentrations were close to the measured values (Fig. 1) . The model predicted that the concentration of PQ in the brain would reach a plateau level by the end of 90 days of dosing. After the mice were transferred to control diet, the PQ residue in the brain declined exponentially, with a PQ half-life of approximately 21 days.
Daily ip doses were simulated, with a dose level set to achieve the same total systemic PQ dose as 24 h of dietary dosing. The mean predicted plasma PQ concentrations were similar for the two dose routes, but the maximum (peak) plasma concentration achieved from ip dosing was 24-times greater than the concentrations resulting from dietary dosing.
Dietary neurotoxicity study -paraquat
Achieved paraquat dose levels
The mean dose levels achieved during the 13 week study for the 10 and 50 ppm PQÁCl 2 groups were 2.4 and 14.1 mg/kg bw/day for males, and 3.7 and 21.5 mg/kg bw/day for females, respectively. The corresponding doses expressed as PQ ion were 1.7 and 10.2 mg/kg bw/day for males, and 2.7 and 15.6 mg/kg bw/day for females, respectively.
Based on the successful simulation of brain PQ concentrations in the kinetic study, as described above, the PBPK model was used to predict the brain PQ concentrations in the dietary neurotoxicity study (Fig. 2) . The predicted maximum PQÁCl 2 concentrations in the brain during the neurotoxicity study were 416 and 655 ng/g tissue at the 50 ppm dose level, and 78 and 125 ng/g tissue at the 10 ppm dose level, for males and females, respectively.
Paraquat effects on body weights, food consumption, and clinical observations
Effects of PQ noted during treatment were limited to a statistically-significantly (p < 0.01) lower mean body weight gain for the 50 ppm PQÁCl 2 males (0.1 g), as compared to control males (0.6 g), over the first week of test diet exposure. Thereafter, there were no treatment-related findings based on the parameters assessed in this study.
Effects of paraquat on striatal neurochemistry
There were no PQ-related effects on striatal dopamine concentrations, dopamine metabolite (DOPAC and HVA) concentrations, or dopamine turnover (Fig. 3) . Based on a lack of a dose-response pattern, none of the differences relating to HVA (females at 10 ppm PQÁCl 2 ) were considered to be related to dietary PQ exposure.
Effects of paraquat on striatal and SNpc neurohistopathology
Dietary exposure to PQ for 4, 8, or 13 weeks did not cause any gross or microscopic damage in any of the brain regions, from the level of the frontal cortex through the striatum and midbrain, including the SNpc. No morphologic changes attributed to PQ exposure were noted with the stains/immunostains that were used to evaluate neuronal cell death (Am Cu Ag), dopaminergic neurons/ processes (TH), astrocytic response (GFAP), microglial response (IBA-1), apoptotic cell death (Caspase 3), nuclear changes (thionine), or DNA fragmentation (TUNEL). Specifically, PQ exposure was not associated with any neuronal, astrocytic, or microglial changes in the substantia nigra or the striatum (Fig. 4) . Representative photomicrographs are presented in Fig. 5 .
Effect of paraquat on SNpc TH + neuronal cell number
There were no statistically-significant effects of PQ in either male or female mice on the number of TH + neurons in the SNpc after 13 weeks of dietary exposure, at either 10 or 50 ppm PQÁCl 2 (Fig. 6) . Brain PQ concentrations in a 13 week kinetic study at dietary dose levels of 0.3 and 1.5 mg/kg/day. Dietary PQÁCl 2 concentrations were adjusted weekly to maintain achieved dose levels at 0.3 and 1.5 mg/kg bw/day. Brains were collected after 7, 56, and 90 days of exposure, and after 30 and 90 days of recovery (n = 3-4 brains/interval/dose level). The curves are PBPK model predictions, which take into account the measured body weight and food consumption data from the study. Fig. 2 . Modeled PQ brain concentrations at 10 and 50 ppm over 13 weeks. Based on the modeling of the dietary kinetic study, as well as the body weight and food consumption data from the neurotoxicity study, the achieved brain PQÁCl 2 concentrations over the exposure period were estimated for male and female mice treated with diet containing PQÁCl 2 at 10 or 50 ppm.
Positive control -MPTP ip MPTP effects on body weights, food consumption, and clinical observations MPTP caused a loss in mean body weight in males and females over the week following MPTP administration. Hunched posture, hypoactivity, piloerection, and/or tremors were observed with increasing incidence, beginning at the time of the second MPTP dose administration and continuing until after the fourth (final) dose.
Effects of MPTP on striatal neurochemistry
MPTP caused a statistically-significant reduction in the striatal concentration of dopamine and its metabolites, DOPAC and HVA, and a statistically-significant increase in dopamine turnover for males, relative to controls (Fig. 3) . The striatal concentration of dopamine in female mice administered MPTP was reduced, although this was not statistically significant compared to controls. Although HVA was statistically-significantly decreased for the MPTP-treated females, in the absence of corresponding changes in DOPAC or dopamine turnover, it is unclear if this lower HVA concentration is a reflection of MPTP treatment.
Effects of MPTP on striatal and SNpc neurohistopathology
Pathologic findings in the SNpc and/or striatum attributed to MPTP included decreased TH immunostaining, increased GFAP immunostaining, and increased IBA-1 immunostaining. Representative photomicrographs are presented in Fig. 5 . Decreased TH immunostaining, consistent with damage to the dopaminergic neurons, was noted in the striatum of all MPTP-treated animals (Fig. 4) . Decreased TH immunostaining in the SNpc was noted for 3/5 males and none of the females. Decreased TH immunostaining was also noted in the ventral tegmental area of the substantia nigra for 3/5 males, but none of the females (data not shown). Increased GFAP immunostaining, indicative of an increase in reactive astrocytes responding to the injury to synaptic terminals in the region, was noted in the striatum for all MPTP-treated males and females. In the SNpc, an increase in astrocyte staining was noted in only 1/5 males and 0/5 females. Increased IBA-1 immunostaining, indicative of a reactive microglial response to tissue damage, was present (severity grade 2/minimal) in the striatum of all males and females. Although not shown in Fig. 5 , the increased IBA-1 immunostaining noted in the striatum following MPTP treatment was similar to that shown previously (Breckenridge et al., 2013) . Increased IBA-1 immunostaining was present in the SNpc of 1/5 males and 0/5 females. Seven days after MPTP treatment, there was no evidence of treatment effects in brain tissues stained/immunostained with Am Cu Ag, Caspase 3, thionine, or TUNEL.
Effect of MPTP on SNpc TH + neuronal cell count
The number of TH + neurons in the SNpc was significantly decreased (by 10%) in MPTP-treated male mice relative to controls. No statistically-significant effects of MPTP on the SNpc were observed in female mice (Fig. 6 ).
Discussion
Among the many studies in the literature that have examined the potential effects of PQ on the SNpc, relatively few studies have involved long-term continuous dosing. Prasad and colleagues (Prasad et al., 2009 ) dosed PQ for up to 12 weeks to male mice via drinking water, but only examined kinetics and measured no endpoints related to neurotoxicity. Gollamudi and associates (Gollamudi et al., 2012) (Ossowska et al., 2005) study; previous studies have indicated that rats are relatively insensitive to MPTP as compared to mice (Giovanni et al., 1994) . The relevance of these dose levels, routes, and durations of exposure to human PQ exposure scenarios, and therefore to human risk assessment, is difficult to assess.
In the current study, the potential effects on the nigrostriatal dopaminergic system were assessed in male and female C57BL/6J mice that were continuously exposed to PQ in the diet for 13 weeks using neurochemistry, neuropathology, and stereology as toxico- logical endpoints as previously described (Breckenridge et al., 2013) . The dietary kinetic study demonstrated that 90 days of dosing was sufficient to achieve a near steady-state concentration of PQ in the brains of C57BL/6J mice, indicating that a longer duration of treatment would not result in a measurably higher concentration of PQ in the brain (Figs. 1 and 2 ). The rate of PQ elimination from the brain (half-life of approximately 21 days) following dietary dosing is consistent with previous reports from studies that used the ip route (Breckenridge et al., 2013; Prasad et al., 2007 Prasad et al., , 2009 . The predicted maximum concentration of PQ in the brain in this dietary study at the 50 ppm dose level (416 and 655 ng PQÁCl 2 /g tissue for males and females, respectively) was comparable to that achieved previously with three weekly ip doses of 10 mg PQÁCl 2 /kg bw (570 ng PQÁCl 2 /g tissue for males; Breckenridge et al., 2013), a dosing regimen commonly used in PQ neurotoxicity studies. In most cases, brain PQ concentrations have not been assessed and/or reported in the literature where the potential damage to the mouse SNpc has been investigated following repeated dosing with PQ. Prasad et al. (2009) reported PQ concentrations in the striatum, frontal cortex, hippocampus, and cerebellum following between 6 and 36 ip PQ doses (10 mg/kg bw/dose) at differing intervals as being in the range 500-2000 ng/g tissue. In these studies the authors reported neurochemical and other changes, and in some cases PQ-related mortality. The PQ concentrations in the present study at the high dietary dose (50 ppm) are within this concentration range, but at the lower end of it. It should be noted that since our data are for whole brain PQ concentrations, any comparisons should be made with caution. Although similar PQ concentrations in the brain can be achieved both by dietary and ip dosing, the dietary route is predicted to produce far less fluctuation in plasma PQ concentration than ip dosing, and therefore would more closely PQ was well tolerated by the C57BL/6J mice in the neurotoxicity study, as indicated by only an initial transient reduction in body weight gain at the top dose. Prolonged exposure to PQ via the diet at 10 and 50 ppm PQÁCl 2 did not result in a reduction in the number of TH + dopaminergic neurons in the SNpc; did not alter the concentration of striatal dopamine or its metabolites; and did not produce evidence of neuronal cell damage or glial activation. Several previous PQ studies have used C57BL/6J male mice (8-12 weeks of age) and multiple (typically three) ip administrations of PQ. The doses used were typically 10 mg PQÁCl 2 /kg bw/ dose occasion. Using this animal model, a number of laboratories have observed a reduction in neuronal cell counts of dopaminergic neurons in the SNpc following ip dosing (Brooks et al., 1999; Jiao et al., 2012; McCormack et al., 2002) . Our ip studies using neuropathology, stereology, and specific stains for glial activation have failed to replicate previously published findings, even with doses of PQ approaching the maximum tolerated dose (25 mg PQÁCl 2 /kg bw/dose by the ip route) (Breckenridge et al., 2013) . In addition, comprehensive neuropathological assessments (in which the pathologist was ''blinded'' to the source of the tissue) have consistently indicated no evidence of neuronal cell damage, cell loss, or an inflammatory response following PQ exposure by the ip route (Breckenridge et al., 2013) . As previously indicated (Breckenridge et al., 2013) , the reason for the discrepancy between these results and those of several previously-published studies (Brooks et al., 1999; Jiao et al., 2012; McCormack et al., 2002; Peng et al., 2004; Yin et al., 2011) is not readily apparent. Jones et al. (2013) noted that PQ-induced nigrostriatal loss is observed only in older mice (generally greater than 3 months of age), and may be associated with age-related iron accumulation in the ventral midbrain. In the current dietary exposure study, the onset of PQ exposure occurred at approximately 2.2 months of age and terminated at approximately 5 months of age, suggesting that these mice should be sensitive to PQ-induced neurotoxicity if age alone is the critical factor in this exposure regimen. However, Jones et al. (2013) further noted that PQ toxicity is a complex phenomenon, and that ''not all individuals, or strains of mice, are likely to be equally susceptible to PQ neurotoxicity''.
Employing the same methodology and similar endpoints as previously described, we now report that prolonged (13 week) dietary There is pronounced and diffuse astrocytosis (as indicated by increased GFAP staining) in the striatum, relative to the normal level of astrocyte staining in the striatum, the SNpc, and the substantia nigra pars reticulata (SNpr). Note that astrocytes are normally somewhat numerous in the SNpr. In the SNpc, there is a detectable linear increase of astrocyte staining in the SNpc, which is the thin layer immediately below the SNpr. This staining indicates an increase of astrocytes/reactive astrocytes in the region of the SNpc, likely due to neuronal loss. 2003) . These toxicological reference doses are based on adverse respiratory system findings in the dog following dietary exposure to PQ. Therefore, the long established toxicological effects of PQ, and in particular, the lung lesions caused by that tissue's selective uptake of PQ (Smith et al., 1990) , remain the most sensitive endpoints found in dietary studies. Consequently, the results from the present study demonstrate that the sensitivity of the lung to PQ continues to be the most appropriate endpoint for determining the NOEL used for deriving reference doses used in human risk assessment. Treatment with MPTP (used as a positive control in this study) resulted in decreased body-weight gain and clinical observations consistent with the reported administration of MPTP (Jackson- Lewis and Przedborski, 2007) . The neurochemistry, neurohistopathology, and stereology findings in the male mice indicate that MPTP damaged dopaminergic neurons in the SNpc and/or striatum. The decrease in striatal dopamine concentrations in male C57BL/6J mice following treatment with MPTP has been reported by many investigators (Irwin et al., 1992; Reinhard et al., 1988) . Activation of microglia and astrocytes (as indicated by the increased IBA-1 and GFAP immunostaining, respectively) are indicative of a neuro-inflammatory response to cellular injury, which has been observed following treatment with toxicants such as 6-hydroxydopamine and MPTP (Herrera et al., 2000; Reinhard et al., 1988; Sheng et al., 1993; Vila et al., 2001) . The absence of MPTP-induced changes in cupric silver staining (indicative of neurodegenerative changes) in the current study is consistent with our previous findings, in which increased Am Cu Ag staining peaked within 48 h of MPTP dosing, but was no longer observed at 168 h (7 days) after dosing (Breckenridge et al., 2013) . The peak of neuronal necrosis in the SNpc is approximately 2-4 days after MPTP administration (Switzer, 2011) , whereas 7 days following MPTP dosing, all evidence of neuronal (and synaptic terminal) disintegration is no longer detectable using the Am Cu Ag stain. The decreases in TH immunostaining noted histopathologically, as well as the reduced number of TH + neurons noted stereologically, in male C57BL/6J mice following MPTP treatment are consistent with many previous investigations (Jackson- Lewis and Smeyne, 2005 ). In the current study, the extent of the reduction in TH + neurons in the SNpc following MPTP dosing was greater for male mice when compared to female mice. The greater effect of MPTP in male versus female mice on striatal dopamine concentrations is consistent with previous findings (Miller et al., 1998 ). This sex difference may be due to a protective estrogenic effect (Dluzen et al., 1996; Shughrue, 2004) .
Conclusion
Exposure of mice to PQ via continuous dietary administration, a paradigm which is more analogous to human exposure than the ip administration route, resulted in a steady-state brain PQ concentration by the end of the 13 week exposure period. No effects of PQ on nigrostriatal dopaminergic processes, as assessed using neurochemistry, stereology, and neuropathology, were noted in the brains from male and female C57BL/6J mice administered PQÁCl 2 in the diet at 50 ppm for 13 weeks (mean dose levels of 10.2 and 15.6 mg PQ ion/kg bw/day for males and females, respectively). The expected damages to, and losses of, dopaminergic neurons, as well as the anticipated reductions in striatal dopamine and its metabolites, were observed following ip treatment with MPTP. 
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